INSMED Inc financial data

Symbol
INSM on Nasdaq
Industry
Pharmaceutical Preparations
Location
700 Us Highway 202/206, Bridgewater, NJ
State of incorporation
VA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 333 % -40.8%
Quick Ratio 24.8 % -34.8%
Debt-to-equity -2.41K % -53%
Return On Equity 1.26K % +74.8%
Return On Assets -54.4 % -11.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 179M shares +25.1%
Common Stock, Shares, Outstanding 179M shares +25%
Entity Public Float 3B USD +30.4%
Common Stock, Value, Issued 1.79M USD +25%
Weighted Average Number of Shares Outstanding, Basic 174M shares +21.6%
Weighted Average Number of Shares Outstanding, Diluted 174M shares +21.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 343M USD +22.1%
Research and Development Expense 556M USD -0.55%
General and Administrative Expense 408M USD +24.3%
Costs and Expenses 1.17B USD +21.3%
Operating Income (Loss) -826M USD -21%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -861M USD -19.2%
Income Tax Expense (Benefit) 3.44M USD +104%
Net Income (Loss) Attributable to Parent -864M USD -19.4%
Earnings Per Share, Basic -5.55 USD/shares -5.11%
Earnings Per Share, Diluted -5.55 USD/shares -5.11%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 461M USD -5.27%
Marketable Securities, Current 1.01B USD +237%
Accounts Receivable, after Allowance for Credit Loss, Current 42.3M USD +18.9%
Inventory, Net 98.5M USD +26.4%
Assets, Current 1.65B USD +78.1%
Property, Plant and Equipment, Net 75.3M USD +16.5%
Operating Lease, Right-of-Use Asset 16M USD -13.1%
Goodwill 136M USD 0%
Assets 2.05B USD +55%
Accounts Payable, Current 65M USD -0.65%
Employee-related Liabilities, Current 55.7M USD +64.4%
Accrued Liabilities, Current 58.8M USD +29%
Liabilities, Current 259M USD +31.7%
Operating Lease, Liability, Noncurrent 9.69M USD -25.6%
Other Liabilities, Noncurrent 3.36M USD -43.3%
Liabilities 1.57B USD -2.77%
Accumulated Other Comprehensive Income (Loss), Net of Tax 547K USD
Retained Earnings (Accumulated Deficit) -4.12B USD -26.5%
Stockholders' Equity Attributable to Parent 483M USD
Liabilities and Equity 2.05B USD +55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -184M USD -25.8%
Net Cash Provided by (Used in) Financing Activities 3.02M USD
Net Cash Provided by (Used in) Investing Activities 295M USD +610%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 179M shares +25%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 113M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 461M USD -5.27%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.21M USD -29.2%
Deferred Tax Assets, Valuation Allowance 904M USD +21.3%
Deferred Tax Assets, Gross 927M USD +20.3%
Operating Lease, Liability 19M USD -12.5%
Depreciation 1.59M USD +27.2%
Payments to Acquire Property, Plant, and Equipment 4.68M USD +37.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -862M USD -19%
Lessee, Operating Lease, Liability, to be Paid 20.2M USD -17%
Property, Plant and Equipment, Gross 124M USD +15.3%
Operating Lease, Liability, Current 7.63M USD +18.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.22M USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.7M USD +5.57%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +14.3%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.11M USD -55.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.11M USD -70.7%
Deferred Tax Assets, Operating Loss Carryforwards 564M USD +13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 14.8M USD +27.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 654K USD -46.3%
Additional Paid in Capital 4.61B USD +55%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.05M USD -0.02%
Deferred Tax Assets, Net of Valuation Allowance 22.5M USD -9.35%
Interest Expense 84.1M USD +8.78%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%